rs80338697
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_138477.4(CDAN1):c.3124C>T(p.Arg1042Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000125 in 1,445,592 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_138477.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152262Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000909 AC: 2AN: 219914Hom.: 0 AF XY: 0.00000840 AC XY: 1AN XY: 119116
GnomAD4 exome AF: 0.0000125 AC: 18AN: 1445592Hom.: 0 Cov.: 32 AF XY: 0.0000125 AC XY: 9AN XY: 717618
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Anemia, congenital dyserythropoietic, type 1a Pathogenic:3Other:1
The homozygous p.Arg1042Trp variant in CDAN1 was identified by our study in 1 individual with anemia, congenital dyserythropoietic, type 1a. The variant has been reported in at least 10 Israeli Bedouin individuals with anemia, congenital dyserythropoietic, type 1a (PMID: 12434312, 18081704), segregated with disease in at least 4 affected relatives from at least one family (PMID: 12434312), and has been identified in 0.01% (1/9396) of Ashkenazi Jewish and 0.006% (1/16548) of East Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs80338697). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. This variant has also been reported in ClinVar (Variation ID: 3176) as pathogenic by OMIM, GeneReviews, and CeGaT Praxis fuer Humangenetik Tuebingen. In vitro functional studies provide some evidence that the p.Arg1042Trp variant may impact protein function (PMID: 22407294). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in at least 10 affected homozygotes, and in at least 10 individuals with anemia, congenital dyserythropoietic, type 1a increases the likelihood that the p.Arg1042Trp variant is pathogenic (PMID: 12434312, 18081704). Multiple variants in the same region as p.Arg1042Trp have been reported in association with disease, suggesting that this variant is in a hot spot and slightly supports pathogenicity (PMID: 18081704). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PP1_strong, PM3, PM1_supporting, PS3_supporting, PP3 (Richards 2015). -
Founder variant in Bedouin population -
- -
The missense variant c.3124C>T (p.Arg1042Trp) in the CDAN1 gene has been reported previously in homozygous state in multiple individuals affected with Congenital dyserythropoietic anaemia. This variant is considered as a founder mutation in Israeli Bedouin patients. In vitro, functional studies provide some evidence that the p.Arg1042Trp variant may impact protein function (Ask et al., 2012; Tamary et al., 2008; Dgany et al., 2002). This variant is reported with the allele frequency (0.0009%) in the gnomAD. It is submitted to ClinVar with varying interpretations as Pathogenic/Likely Pathogenic. The amino acid Arginine at position 1042 is changed to a Tryptophan changing protein sequence and it might alter its composition and physico-chemical properties. Multiple lines of computational evidence (Polyphen - Damaging, SIFT - Damaging) predict a damaging effect on protein structure and function for this variant. The amino acid change p.Arg1042Trp in CDAN1 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. -
Congenital dyserythropoietic anemia, type I Pathogenic:1
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at